New Jersey 2022-2023 Regular Session

New Jersey Senate Bill S2616

Introduced
5/12/22  

Caption

Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances.

Impact

The bill establishes a per se standard for determining the influence of marijuana and certain controlled dangerous substances in drivers. Specifically, it states that any driver found to have three nanograms or more of delta 9-tetrahydrocannabinol (THC) per milliliter of blood would be considered under the influence. This clear standard is intended to support law enforcement efforts in dealing with drugged driving, which has become an increasing concern in the context of marijuana legalization in various states.

Summary

Senate Bill S2616 aims to amend the existing statutes concerning driving under the influence (DUI) laws in New Jersey by expanding the implied consent law to include blood testing. This legislative measure is designed to enhance law enforcement's ability to ascertain whether a driver is operating a vehicle under the influence of not only alcohol but also narcotics, hallucinogenic substances, and other drugs. Under the proposed bill, individuals consent to such tests simply by operating a motor vehicle on public roads. If a person refuses to provide a blood sample, they would face the same legal penalties as those who refuse a breath test for alcohol intoxication.

Conclusion

In summary, S2616 endeavors to modernize New Jersey's DUI laws and tackle the complex issue of drugged driving head-on. By incorporating blood testing into the implied consent scheme, the legislation aims to create clearer guidelines for law enforcement and encourage safer driving practices among all road users.

Contention

While proponents argue that S2616 will bolster road safety and provide law enforcement with necessary tools for addressing drug-impaired driving, there are concerns regarding civil liberties and the implications of expanding implied consent laws. Critics might question the fairness of assuming consent for a blood test and the potential consequences for individuals who may refuse testing, even if they believe they are not impaired. Supporters also emphasize that law enforcement must maintain proper procedures, ensuring that tests are conducted ethically and that drivers are informed of their rights.

Companion Bills

No companion bills found.

Previously Filed As

NJ S279

Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances.

NJ A2902

Expands implied consent law to include blood testing; establishes per se standard for driving under influence of marijuana and certain controlled dangerous substances.

NJ A2786

Extends penalties for driving under the influence to include any substance that impairs driving ability; deems driver's consent to non-invasive drug tests.

NJ HB3766

Driving under the influence; updating statutory references; setting requirements for driving under the influence of a controlled substance; effective date.

NJ HB34

AN ACT relating to driving under the influence of marijuana.

NJ SB230

AN ACT relating to driving under the influence of marijuana.

NJ HB3018

Driving under the influence; making certain exception for marijuana, marijuana derivatives, and synthetic cannabinoids; effective date.

NJ S0052

Driving under the influence

NJ H4005

Driving under the influence

NJ HB5406

Relating to driving under the influence

Similar Bills

No similar bills found.